ESR1 and breast cancer: Several prospective clinical trials demonstrated the efficacy of selective estrogen receptor modulators (Cuzick et al., 2013) (i.e., tamoxifen, raloxifene) and aromatase inhibitors exemestane (Goss et al., 2011) and anastrozole (Cuzick et al., 2014) for preventing BC in unselected women.